BLEECKER (BLEE.PA) Stock Fundamental Analysis

EPA:BLEE • FR0000062150

135 EUR
+7 (+5.47%)
Last: Feb 25, 2026, 07:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BLEE. BLEE was compared to 43 industry peers in the Diversified REITs industry. BLEE has a bad profitability rating. Also its financial health evaluation is rather negative. BLEE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year BLEE has reported negative net income.
  • BLEE had a positive operating cash flow in the past year.
  • BLEE had negative earnings in 4 of the past 5 years.
  • Each year in the past 5 years BLEE had a positive operating cash flow.
BLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFBLEE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

1.2 Ratios

  • BLEE's Return On Assets of -1.55% is on the low side compared to the rest of the industry. BLEE is outperformed by 76.74% of its industry peers.
  • BLEE has a worse Return On Equity (-3.77%) than 79.07% of its industry peers.
  • BLEE's Return On Invested Capital of 0.92% is on the low side compared to the rest of the industry. BLEE is outperformed by 79.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLEE is below the industry average of 3.59%.
Industry RankSector Rank
ROA -1.55%
ROE -3.77%
ROIC 0.92%
ROA(3y)-4.02%
ROA(5y)-0.44%
ROE(3y)-9.45%
ROE(5y)-1.9%
ROIC(3y)1.2%
ROIC(5y)0.87%
BLEE.PA Yearly ROA, ROE, ROICBLEE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • BLEE's Operating Margin of 28.66% is on the low side compared to the rest of the industry. BLEE is outperformed by 72.09% of its industry peers.
  • BLEE's Operating Margin has improved in the last couple of years.
  • BLEE has a worse Gross Margin (48.70%) than 72.09% of its industry peers.
  • BLEE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 28.66%
PM (TTM) N/A
GM 48.7%
OM growth 3Y50.6%
OM growth 5Y1.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.93%
GM growth 5Y6.49%
BLEE.PA Yearly Profit, Operating, Gross MarginsBLEE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1

2. Health

2.1 Basic Checks

  • BLEE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BLEE has about the same amount of shares outstanding.
  • Compared to 5 years ago, BLEE has about the same amount of shares outstanding.
  • Compared to 1 year ago, BLEE has a worse debt to assets ratio.
BLEE.PA Yearly Shares OutstandingBLEE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M
BLEE.PA Yearly Total Debt VS Total AssetsBLEE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 0.82, we must say that BLEE is in the distress zone and has some risk of bankruptcy.
  • BLEE has a Altman-Z score of 0.82. This is comparable to the rest of the industry: BLEE outperforms 46.51% of its industry peers.
  • BLEE has a debt to FCF ratio of 50.91. This is a negative value and a sign of low solvency as BLEE would need 50.91 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 50.91, BLEE is not doing good in the industry: 72.09% of the companies in the same industry are doing better.
  • BLEE has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
  • BLEE has a worse Debt to Equity ratio (1.22) than 79.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 50.91
Altman-Z 0.82
ROIC/WACC0.19
WACC4.87%
BLEE.PA Yearly LT Debt VS Equity VS FCFBLEE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.56 indicates that BLEE may have some problems paying its short term obligations.
  • The Current ratio of BLEE (0.56) is comparable to the rest of the industry.
  • BLEE has a Quick Ratio of 0.56. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BLEE's Quick ratio of 0.56 is fine compared to the rest of the industry. BLEE outperforms 60.47% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
BLEE.PA Yearly Current Assets VS Current LiabilitesBLEE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 77.23% over the past year.
  • The Revenue for BLEE has decreased by -18.19% in the past year. This is quite bad
  • Measured over the past years, BLEE shows a small growth in Revenue. The Revenue has been growing by 1.50% on average per year.
EPS 1Y (TTM)77.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.77%
Revenue 1Y (TTM)-18.19%
Revenue growth 3Y0.82%
Revenue growth 5Y1.5%
Sales Q2Q%-15.48%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLEE.PA Yearly Revenue VS EstimatesBLEE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BLEE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLEE.PA Price Earnings VS Forward Price EarningsBLEE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, BLEE is valued a bit more expensive than the industry average as 65.12% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 23.55
EV/EBITDA N/A
BLEE.PA Per share dataBLEE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 15.60%, BLEE is a good candidate for dividend investing.
  • BLEE's Dividend Yield is rather good when compared to the industry average which is at 5.12. BLEE pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, BLEE pays a better dividend.
Industry RankSector Rank
Dividend Yield 15.6%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BLEE.PA Yearly Dividends per shareBLEE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2026 10 20 30 40

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
BLEE.PA Yearly Income VS Free CF VS DividendBLEE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M

BLEECKER

EPA:BLEE (2/25/2026, 7:00:00 PM)

135

+7 (+5.47%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-27
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners71.74%
Ins Owner ChangeN/A
Market Cap152.55M
Revenue(TTM)24.51M
Net Income(TTM)-9.41M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 15.6%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.22
P/FCF 23.55
P/OCF 10.69
P/B 0.61
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)-8.37
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)5.73
FCFY4.25%
OCF(TTM)12.62
OCFY9.35%
SpS21.69
BVpS221.1
TBVpS218.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.55%
ROE -3.77%
ROCE 1.25%
ROIC 0.92%
ROICexc 0.92%
ROICexgc 0.92%
OM 28.66%
PM (TTM) N/A
GM 48.7%
FCFM 26.43%
ROA(3y)-4.02%
ROA(5y)-0.44%
ROE(3y)-9.45%
ROE(5y)-1.9%
ROIC(3y)1.2%
ROIC(5y)0.87%
ROICexc(3y)1.21%
ROICexc(5y)0.87%
ROICexgc(3y)1.22%
ROICexgc(5y)0.88%
ROCE(3y)1.64%
ROCE(5y)1.18%
ROICexgc growth 3Y51.04%
ROICexgc growth 5Y4.77%
ROICexc growth 3Y51.05%
ROICexc growth 5Y4.77%
OM growth 3Y50.6%
OM growth 5Y1.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.93%
GM growth 5Y6.49%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 50.91
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 31.77%
Interest Coverage 0.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z 0.82
F-Score5
WACC4.87%
ROIC/WACC0.19
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)19.59%
Cap/Sales(5y)39.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.19%
Revenue growth 3Y0.82%
Revenue growth 5Y1.5%
Sales Q2Q%-15.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.45%
EBIT growth 3Y51.83%
EBIT growth 5Y3.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y884.35%
FCF growth 3YN/A
FCF growth 5Y6.31%
OCF growth 1Y76.82%
OCF growth 3Y279.98%
OCF growth 5Y9.63%

BLEECKER / BLEE.PA FAQ

What is the ChartMill fundamental rating of BLEECKER (BLEE.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BLEE.PA.


What is the valuation status for BLEE stock?

ChartMill assigns a valuation rating of 0 / 10 to BLEECKER (BLEE.PA). This can be considered as Overvalued.


Can you provide the profitability details for BLEECKER?

BLEECKER (BLEE.PA) has a profitability rating of 2 / 10.


Is the dividend of BLEECKER sustainable?

The dividend rating of BLEECKER (BLEE.PA) is 6 / 10 and the dividend payout ratio is 0%.